Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer.

The 67 hypermethylated regions were analyzed in our cfMeDIP-seq data, and a synoptic methylation score was calculated, showing an increasing trend from controls to lPCa to aPCa in both plasma and urine (Fig. 1d ).

also in 63,971 other papers